NEW
YORK, Sept. 20, 2024 /PRNewswire/ -- Report on
how AI is redefining market landscape - The global soft tissue
repair market size is estimated to grow by USD 3.29 billion from 2024-2028, according to
Technavio. The market is estimated to grow at a CAGR of
over 4.2% during the forecast period. Rising
incidence of accidental injuries is driving market
growth, with a trend towards growing demand for gene
therapy However, high cost of clinical trials and
failure rate in clinical trials poses a challenge - Key
market players include 3M Co., Acera
Surgical Inc., AlloSource, Arthrex Inc., Artivion Inc.,
Becton Dickinson and Co., Conmed
Corp., Ed. Geistlich Sohne AG, Integra Lifesciences Corp., Johnson
and Johnson Services Inc., JRF Ortho, Koninklijke DSM NV, LifeCell
International Pvt. Ltd., LifeNet Health Inc., Medtronic Plc, RTI
Surgical Inc., Smith and Nephew plc, Stryker Corp., Tissue Regenix
Group Plc, and Zimmer Biomet Holdings Inc..
AI-Powered Market Evolution Insights. Our
comprehensive market report ready with the latest trends, growth
opportunities, and strategic analysis- View your snapshot
now
Forecast
period
|
2024-2028
|
Base Year
|
2023
|
Historic
Data
|
2018 - 2022
|
Segment
Covered
|
End-user (Hospitals,
Ambulatory surgical services, and Clinics), Product (Soft tissue
fixation devices and accessories, Cell therapy, and Tissue
scaffold), and Geography (North America, Europe, Asia, and Rest of
World (ROW))
|
Region
Covered
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Key companies
profiled
|
3M Co., Acera Surgical
Inc., AlloSource, Arthrex Inc., Artivion Inc., Becton Dickinson and
Co., Conmed Corp., Ed. Geistlich Sohne AG, Integra Lifesciences
Corp., Johnson and Johnson Services Inc., JRF Ortho, Koninklijke
DSM NV, LifeCell International Pvt. Ltd., LifeNet Health Inc.,
Medtronic Plc, RTI Surgical Inc., Smith and Nephew plc, Stryker
Corp., Tissue Regenix Group Plc, and Zimmer Biomet Holdings
Inc.
|
Key Market Trends Fueling Growth
Gene therapy holds great promise in the field of soft tissue
repair, with approximately 65% of clinical trials focusing on
cancer therapy. Researchers are exploring gene therapy's potential
for wound healing by manipulating the tissue growth factor beta
(TGF-beta), which induces cell proliferation and aids in healing.
In Europe, GlaxoSmithKline, in
collaboration with the San Raffaele Telethon Institute for Gene
Therapy and Milanese biotech MoIMed, has developed Strimvelis, an
investigational gene therapy product awaiting European Commission
approval. Though no gene therapy products are approved in the US,
Abeona Therapeutics is developing a gene therapy product, EB-101,
for wound healing and has initiated a Phase II trial for recessive
dystrophic epidermolysis bullosa. Positive clinical results and
product approval will significantly expand the global soft tissue
repair market.
The Soft Tissue Repair market is witnessing significant growth
due to the increasing number of orthopedic procedures for trauma
patients and sports injuries. The obesity rate is also driving
demand, as excess weight puts pressure on muscles, fibrous tissue,
blood vessels, and connective tissues, leading to various
musculoskeletal disorders. The geriatric population and those with
chronic diseases like cystic fibrosis, hepatitis, cardiovascular
disease, cancer, and age-related physiological changes require soft
tissue repair. Surgeons use tissue patches or synthetic meshes for
soft tissue restoration. Companies like Myriad and Aroa Biosurgery
lead the market with their surgical mesh portfolios. Hernia cases
are common, and resorbable polymer technology offers a solution.
Lifestyle concerns, such as obesity and osteoporosis, and metabolic
inefficiencies, contribute to the market's growth. Soft tissue
repair is essential for treating various conditions, including low
back discomfort, neck pain, osteoarthritis, fractures, amputations,
rheumatoid arthritis, and surgical procedures for hernia repair,
adult inguinal hernias, and other musculoskeletal
disorders.
Insights on how AI is driving innovation,
efficiency, and market growth- Request Sample!
Market Challenges
- The soft tissue repair market involves significant investments
for vendors, particularly during the clinical trial phase. Most
trials are conducted in high-income countries like the US, UK,
Germany, France, Japan, Singapore, and South
Korea, resulting in high costs for product development and
launch. Small vendors and start-ups often seek funding, but
resources are limited. The cost of bringing a soft tissue repair
product, such as cell therapy-based treatments, from pre-clinical
development to approval can reach up to USD1.5 billion. Factors like dosing, delivery,
toxicity, and immune rejection must be addressed during clinical
trials. Failure to identify these factors in the pre-clinical stage
can lead to high failure rates and economic burdens for vendors. A
study by the Public Health Department, Aix Marseille University,
and Creativ-Ceutical found that of the 939 clinical trials for
advanced therapy medicinal products (ATMPs), only 53.6% were for
somatic cell therapies, and only five ATMPs were granted approval,
including one cell therapy product, PROVENGE. These challenges may
hinder the growth of the global soft tissue repair market during
the forecast period.
- The Soft Tissue Repair market encompasses various segments,
including Skin repair, Orthopaedic repair, Dental repair, and
Breast reconstruction repair. Challenges in this industry include
injuries from hospitals, clinics, ambulatory surgery centers,
emergency care centers, and burn care centers. Soft tissue
injuries, such as strains, tendon damage, and ligament tears,
result from road traffic crashes, accidents, and sports-related
incidents. An aging population with chronic conditions like
diabetes-related gangrene, peripheral vascular disease, and
osteoporosis-related fractures fuels demand. Regulatory approval
for biomaterials, cells, and biomolecules used in suturing
techniques and synthetic materials is crucial. Market segments
include Allograft and Orthopedics, with applications in tumors,
infections, spine diseases, congenital disorders, and traumatic
brain injuries.
Insights into how AI is reshaping industries and
driving growth- Download a Sample Report
Segment Overview
This soft tissue repair market report extensively covers market
segmentation by
- End-user
- 1.1 Hospitals
- 1.2 Ambulatory surgical services
- 1.3 Clinics
- Product
- 2.1 Soft tissue fixation devices and accessories
- 2.2 Cell therapy
- 2.3 Tissue scaffold
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Hospitals- Hospitals are significant
buyers in the soft tissue repair market due to the increasing
demand for these products in various departments. Large hospitals,
with over 500 beds, are key consumers, procuring in bulk and
engaging with multiple suppliers. Their advanced medical
infrastructure caters to a larger patient base, leading to an
increased need for soft tissue repair solutions. Medium-sized
hospitals, with around 200-300 beds, also contribute to market
growth. Their decentralized administration and growing
number of emergency department visits, particularly for TBI and
orthopedic cases, necessitate the use of soft tissue repair
products. This trend is expected to continue driving the growth of
the hospitals segment in the global soft tissue repair market.
Download complimentary Sample Report to
gain insights into AI's impact on market dynamics, emerging trends,
and future opportunities- including forecast (2024-2028) and
historic data (2018 - 2022)
Research Analysis
Soft tissue repair refers to the process of restoring damaged
muscle, fibrous tissue, blood vessels, and connective tissues. This
procedure is commonly used in orthopedic surgeries for various
conditions such as trauma injuries, sports injuries, strains,
tendon damage, and ligament tears. Trauma patients, including those
from road traffic crashes and sports-related incidents, often
require soft tissue repair. The repair techniques include
transabdominal preperitoneal repair and completely extraperitoneal
repair. Additionally, soft tissue repair is essential for
individuals with conditions like hernia, rotator cuff tear, cystic
fibrosis, hepatitis, cardiovascular disorders, and cancer. Aroa
Biosurgery is a leading technology in soft tissue restoration,
providing innovative solutions for wound care and tissue repair.
Soft tissue injuries can significantly impact a patient's quality
of life, and timely and effective repair is crucial for
recovery.
Market Research Overview
The global soft tissue repair market is witnessing significant
growth due to the increasing prevalence of orthopedic procedures,
trauma patients, and sports injuries. Soft tissue repair involves
the restoration of damaged muscles, fibrous tissue, blood vessels,
and connective tissues using various techniques such as surgical
procedures and tissue patches/meshes. The obesity rate is also a
major factor driving the market growth as obesity increases the
risk of musculoskeletal disorders, including hernia cases.
Age-related physiological changes, chronic diseases like cystic
fibrosis, hepatitis, cardiovascular disease, and cancer, also
contribute to the market growth. Psychological pressure, geriatric
population, and metabolic inefficiencies are other factors driving
the demand for soft tissue repair. The market includes various
players offering tissue patch/mesh, synthetic mesh, and biologics.
Orthopedic surgeries, extracellular matrix, and resorbable polymer
technology are some of the key trends in the market. The market
caters to various surgical care facilities, including hospitals,
clinics, ambulatory surgery centers, emergency care centers, and
burn care centers. Soft tissue injuries from strains, tendon
damage, ligament tears, road traffic crashes, and accidents are
common and require surgical intervention. The baby boomer
population and the increasing prevalence of chronic conditions like
diabetes-related gangrene and peripheral vascular disease also
contribute to the market growth. The market includes various
surgical procedures, including laparoscopic instrument injectors,
dural repair, vaginal sling procedures, skin repair, orthopaedic
repair, dental repair, and breast reconstruction repair. Skilled
surgeons and clinical trials are essential to the market's growth,
and medical tourism is also a significant factor influencing the
market dynamics.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- End-user
-
- Hospitals
- Ambulatory Surgical Services
- Clinics
- Product
-
- Soft Tissue Fixation Devices And Accessories
- Cell Therapy
- Tissue Scaffold
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/the-soft-tissue-repair-market-is-expected-to-grow-by-usd-3-29-billion-from-2024-2028--driven-by-rising-accidental-injuries-and-ais-impact-on-market-trends--technavio-302254184.html
SOURCE Technavio